Extractables and leachables considerations for prefilled syringes
- PMID: 24955780
- DOI: 10.1517/17425247.2014.928281
Extractables and leachables considerations for prefilled syringes
Abstract
Introduction: Use of pre-filled syringes as both a packaging and delivery system for pharmaceutical drug products is accelerating. Pre-filled syringes must meet the quality and suitability for use requirements for both systems, including compatibility with the drug product. Relevant incompatibilities between pre-filled syringes and drug products include the safety of syringe-based leachables that accumulate in drug products and the ability of leachables to interact with the drug product's ingredients as such interactions can affect safety, efficacy, stability and physical viability.
Areas covered: Relevant suitability considerations for pre-filled syringes are discussed herein and specific examples of suitability for use issues for pre-filled syringes are cited, focusing on extractables associated with pre-filled syringes and leachables derived from such syringes. Aspects considered include the toxicological impact of leachables, their ability to alter the efficacy of drug products and to produce other undesirable outcomes such as aggregation and immunogenic responses.
Expert opinion: Materials used in pre-filled syringes and the conditions of use minimize the traditional safety risk associated with leachables. However, drug products that use pre-filled syringes are prone to non-traditional interactions such as disruption of protein conformation, leading to potential efficacy, safety and quality issues. In order to qualify pre-filled syringes for use, the traditional approach of measuring extractables and leachables and inferring their effect must be augmented by rigorous compatibility testing. Research into the fundamental relationship between leachables and drug substances will be necessary so the more time- and cost-efficient 'measure and infer' approach can be widely implemented.
Keywords: aggregation; extractables; incompatibilities; leachables; pre-filled syringes; safety.
Similar articles
-
A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):407-55. doi: 10.5731/pdajpst.2014.00995. PDA J Pharm Sci Technol. 2014. PMID: 25336416
-
Holistic Extractables and Leachables Program: Evaluations of Prefilled Syringe Systems for Biotechnology Products.PDA J Pharm Sci Technol. 2020 Nov-Dec;74(6):627-643. doi: 10.5731/pdajpst.2019.011379. Epub 2020 Jul 16. PDA J Pharm Sci Technol. 2020. PMID: 32675308
-
Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.PDA J Pharm Sci Technol. 2015 Sep-Oct;69(5):590-619. doi: 10.5731/pdajpst.2015.01073. PDA J Pharm Sci Technol. 2015. PMID: 26429108
-
The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).PDA J Pharm Sci Technol. 2013 Sep-Oct;67(5):430-47. doi: 10.5731/pdajpst.2013.00936. PDA J Pharm Sci Technol. 2013. PMID: 24084659 Review.
-
Prefilled dual chamber devices (DCDs) - Promising high-quality and convenient drug delivery system.Int J Pharm. 2021 Mar 15;597:120314. doi: 10.1016/j.ijpharm.2021.120314. Epub 2021 Feb 2. Int J Pharm. 2021. PMID: 33540011 Review.
Cited by
-
Silicone Oil Microdroplets Can Induce Antibody Responses Against Recombinant Murine Growth Hormone in Mice.J Pharm Sci. 2016 May;105(5):1623-1632. doi: 10.1016/j.xphs.2016.02.019. Epub 2016 Mar 25. J Pharm Sci. 2016. PMID: 27020987 Free PMC article.
-
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy.Pharm Res. 2024 Mar;41(3):419-440. doi: 10.1007/s11095-023-03649-z. Epub 2024 Feb 17. Pharm Res. 2024. PMID: 38366236 Review.
-
MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France.MAbs. 2017 May/Jun;9(4):579-585. doi: 10.1080/19420862.2017.1298899. Epub 2017 Feb 28. MAbs. 2017. PMID: 28346048 Free PMC article.
-
Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics.MAbs. 2018 Jan;10(1):18-33. doi: 10.1080/19420862.2017.1392424. Epub 2017 Nov 7. MAbs. 2018. PMID: 29035675 Free PMC article. Review.
-
Container Closure and Delivery Considerations for Intravitreal Drug Administration.AAPS PharmSciTech. 2021 Mar 11;22(3):100. doi: 10.1208/s12249-021-01949-4. AAPS PharmSciTech. 2021. PMID: 33709236 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical